NASDAQ: IMMRImmersion Corp Stock
$7.07-0.22 (-3.02%)
Updated Apr 17, 2025
IMMR Price
$7.07
Fair Value Price
$4.50
Market Cap
$229.04M
52 Week Low
$6.47
52 Week High
$13.94
P/E
N/A
P/B
0.72x
P/S
N/A
PEG
N/A
Dividend Yield
1.91%
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
2.52
Operating Cash Flow
N/A
Beta
1.11
Next Earnings
May 6, 2025
Ex-Dividend
N/A
Next Dividend
N/A
IMMR Overview
Immersion Corporation, together with its subsidiaries, invents, scales, and licenses haptic technologies that allow people to use their sense of touch to engage with and experience various digital products in North America, Europe, and Asia. The company provides technology, patent, and combined licenses. It also provides software development kits (SDKs) comprising tools, integration software, and effect libraries that allow for the design, encoding, and playback of tactile effects in content. In addition, the company offers reference designs and reference technology, engineering and integration services, and software and firmware services. The company offers its products to mobile communications, wearables, and consumer electronics; gaming and virtual reality (VR); automotive; and other markets. Immersion Corporation was incorporated in 1993 and is headquartered in Aventura, Florida.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine IMMR's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important IMMR news, forecast changes, insider trades & much more!
IMMR News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IMMR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
IMMR ($7.07) is overvalued by 57.05% relative to our estimate of its Fair Value price of $4.50 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
IMMR ($7.07) is not significantly undervalued (57.05%) relative to our estimate of its Fair Value price of $4.50 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
IMMR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 35 more IMMR due diligence checks available for Premium users.
Valuation
IMMR fair value
Fair Value of IMMR stock based on Discounted Cash Flow (DCF)
Price
$7.07
Fair Value
$4.50
Overvalued by
57.05%
IMMR ($7.07) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
IMMR ($7.07) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
IMMR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
111.58x
Market
27.98x
IMMR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.72x
Industry
6.37x
IMMR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
IMMR's financial health
Profit margin
Revenue
$474.8M
Net Income
$15.5M
Profit Margin
3.3%
Assets to liabilities
Assets
$1.4B
Liabilities
$804.3M
Debt to equity
2.52
IMMR's short-term assets ($925.98M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IMMR's short-term assets ($925.98M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IMMR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
IMMR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$43.7M
Investing
$8.7M
Financing
$22.3M
IMMR vs App Stocks
Immersion Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.